Has Stanton Elzi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,236,602 in general payments to Stanton Elzi, MD across 1,272 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stanton Elzi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stanton Elzi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stanton Elzi, MD

Internal Medicine · Wheat Ridge, CONPI 1417035502

Payments from drug & device makers

$9,236,602in general payments, 2019–2025

Across 1,272 payments — averaging $7261.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Research & Development, LLC$3.5M
Modernatx, Inc.$2.6M
Pfizer$949K
Johnson & Johnson$678K
Merck$497K
Vertex$228K
plus $753K from 49 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Research & Development, LLC	97	$3,542,814
Modernatx, Inc.	183	$2,588,485
Pfizer	173	$949,188
Johnson & Johnson	82	$678,255
Merck	36	$497,216
Vertex	3	$227,810
Seqirus USA Inc	98	$226,404
Sanofi Pasteur Inc.	9	$224,050
Vanda Pharmaceuticals Inc.	21	$110,459
Biogen	3	$78,575
GSK	69	$37,345
AstraZeneca(2 entities)	51	$27,044
Regeneron	5	$24,052
Amgen(2 entities)	32	$17,936
AbbVie(2 entities)	60	$1,105
Novo Nordisk	70	$1,103
Boehringer Ingelheim	51	$891
Lilly USA, LLC	54	$762
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	23	$329
Astellas Pharma US Inc	11	$217
Grifols USA, LLC	10	$215
Novartis	12	$212
Nestle Healthcare Nutrition Inc.	15	$181
Amarin Pharma, Inc.	9	$155
E.r. Squibb & Sons, L.L.C.	7	$154
Biohaven Pharmaceuticals, Inc.	6	$151
Bayer	9	$151
Kowa Pharmaceuticals America, Inc.	8	$115
Biohaven Pharmaceutical Holding Company Ltd.	4	$106
Abbott	4	$95
Sumitomo Pharma America, Inc.	4	$93
Aimmune Therapeutics, Inc.	5	$93
Sanofi-aventis U.S. LLC	5	$80
Eisai Inc.	6	$79
Medtronic(2 entities)	3	$72
Esperion Therapeutics, Inc.	4	$58
Sunovion Pharmaceuticals Inc.	3	$55
Boston Scientific	2	$55
Nevro Corp.	3	$50
Otsuka America Pharmaceutical, Inc.	2	$41
Bausch Health US, LLC	2	$38
Dexcom, Inc.	2	$35
Avanir Pharmaceuticals, Inc.	2	$33
Amphastar Pharmaceuticals, Inc.	1	$32
Mannkind Corporation	2	$31
Janssen Scientific Affairs, LLC	1	$27
Dermira, Inc.	2	$27
Exact Sciences	1	$21
Idorsia Pharmaceuticals US Inc	1	$21
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
United Therapeutics Corporation	1	$16
Radius Health, Inc.	1	$15
Daiichi Sankyo Inc.	1	$14
Gilead	1	$12
Shire North American Group Inc	1	$11

How this compares

$9,236,602 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado →

Medicare billing

Part B allowed, 2024

$165,474

Medicare patients

970

Services billed

4,602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Wheat Ridge

William AllanWheat Ridge$13K
Jason HenryDenver$7.3M
Kenneth CohenLakewood$4.5M
Luke WebbColorado Springs$2.1M
Alexis LealAurora$2M
Mauricio WaintrubAurora$1.3M
Steven BrodieColorado Springs$883K
Monica GrafalsAvon$673K
Gilad GordonBoulder$476K
Kathryn PolovitzParker$403K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →